Is it time to stock up on wine? This pandemic could stretch out — and that has some major market implications
Bernstein analyst Ronny Gal has some good news and some bad news related to the pandemic.
So what do you want to hear first?
It’s the end of the week, so let’s start off on something sweet before we turn to the sour.
In Gal’s seasoned opinion, there are positive notes being sounded in the fight against Covid-19. These new variants, he writes, are still being knocked back by the approved vaccines, and the mRNA jabs from Moderna and Pfizer/BioNTech demonstrated enough of a knockout punch against the Brand A virus to allow for a drop of efficacy on the variants while still offering herd immunity.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.